Inhibikase Therapeutics, Inc. | ||||
NCM : IKT || Location: United States | ||||
$2.16-0.14 (-6.09%) |
0.1 M | 2.08 - 2.44 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 0.030 M |
Feb. 29, 2024 | 0.051 M |
Feb. 15, 2024 | 0.085 M |
Jan. 31, 2024 | 0.062 M |
Jan. 12, 2024 | 0.009 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
09/30/2023 | -1.13 | -0.86 | 23.97% |
06/30/2023 | -0.93 | -1.11 | -19.46% |
03/31/2023 | -0.88 | -0.96 | -9.25% |
12/31/2022 | -1.15 | -1.08 | 6.20% |
09/30/2022 | -1.08 | -1.08 | 0.00% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 6.186M | Shares Float | 5.531M |
Short Float | 0.030M | Market Cap | 13.36M |
Institution ownership | 10.28% | Insider ownership | 19.214% |
Earnings Date | 05/13/2024 AMC | Cash Per Share | ? |
Trailing EPS | -3.99 | Forward EPS | -1.77 |